Texas 2021 - 87th Regular

Texas Senate Bill SB184

Caption

Relating to reports on the prevalence of eating disorders and eating disorder-related deaths in this state.

Impact

The enactment of SB 184 is expected to enhance awareness and understanding of eating disorders within Texas. By mandating the collection of data on prevalence and mortality rates, the bill aims to provide lawmakers and health officials with critical insights needed to formulate targeted interventions. This effort could potentially lead to improved health services and resources for those affected by these disorders, thereby addressing a significant public health concern. Moreover, the reports could serve as a basis for advocating for more robust funding and initiatives aimed at tackling eating disorders in the region.

Summary

Senate Bill 184 focuses on addressing the pressing issue of eating disorders and the associated fatalities in Texas. This legislation mandates the Department of State Health Services (DSHS) to compile comprehensive reports regarding the prevalence of eating disorders and eating disorder-related deaths across the state. Additionally, the bill requires DSHS to analyze national trends and evaluate state-funded behavioral health treatment options available for individuals suffering from eating disorders. The initial report is due by December 1, 2023, with a subsequent report on youth eating disorders scheduled for December 1, 2024.

Sentiment

General sentiment around SB 184 is supportive, particularly among health advocates and professionals who recognize the growing concerns surrounding eating disorders in society. By prioritizing data collection and transparency regarding eating disorder prevalence, the bill is viewed favorably as a proactive step toward better health outcomes. However, there may be concerns regarding the adequacy of funding and resources to implement the recommendations that may arise from the reports.

Contention

While the bill enjoys broad support, debates may arise on how effectively the collected data will be utilized and whether it will adequately influence policy changes or funding allocations. Opponents could express concerns about the potential for bureaucratic delays in executing the findings, and there may be questions about the adequacy of state resources to ensure effective follow-through on the report's recommendations. Overall, the bill sets the foundation for an essential dialogue on mental health and the need for systematic support in dealing with eating disorders.

Companion Bills

TX HB551

Same As Relating to reports on the prevalence of eating disorders and eating disorder-related deaths in this state.

Previously Filed As

TX SB63

Relating to an instruction guide for family members and caregivers of veterans who have mental health disorders.

TX HB1673

Relating to training requirements for staff members of certain assisted living facilities that provide care to persons with Alzheimer's disease and related disorders.

TX HB950

Relating to a student's eligibility for special education services provided by a school district, including services for dyslexia and related disorders.

TX SB2487

Relating to a student's eligibility for special education services provided by a school district, including services for dyslexia and related disorders.

TX HB1313

Relating to a study on the side effects, adverse reactions, including death, and the effectiveness of vaccines against the SARS-CoV-2 virus (COVID-19) or its variants.

TX HB1369

Relating to a student's eligibility for special education services provided by a school district, including services for dyslexia and related disorders.

TX HB1463

Relating to a state plan and requirements for nursing facilities and related institutions that provide care and treatment for persons with Alzheimer's disease and related disorders.

TX HB4505

Relating to health benefit plan coverage for treatment of autism spectrum disorders.

TX SB403

Relating to a study on the adverse reactions and efficacy of COVID-19 vaccines.

TX HB755

Relating to prior authorization for prescription drug benefits related to the treatment of autoimmune diseases and certain blood disorders.

Similar Bills

No similar bills found.